Anti-glutamic acid decarboxylase (GAD) antibody is associated with many eye movement disorders, including downbeat and periodic alternating nystagmus, ocular flutter and opsoclonus, and ophthalmoplegia with or without stiff person syndrome (SPS) or cerebellar dysfunction (84–87). Here, GAD1 is linked to stiff-person syndrome.